Replies to post #384504 on Elite Pharmaceuticals Inc (ELTP)

[imanjen13]

I believe NH said that if 2 of the three current ANDAs were approved it would be significant. The problem with Oxy is the current status of the litigation and the delay due to the launch line. That why I bring my own launch to school.

[The ELTP King]

And you are correct.

I was under the impression that none of the products considered needle movers have been filed yet.